Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results View Full Press Release Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results